cover image: 13 th - April 2021  Dr. Ngozi Okonjo-Iweala Director General

20.500.12592/1zx6w2

13 th - April 2021 Dr. Ngozi Okonjo-Iweala Director General

14 Apr 2021

We have also observed from publicly available information that in some agreements the technology holder maintains control over the vaccine component and prevents the licensee from manufacturing the vaccine component, hence creating dependency on the technology holder for the supply of the vaccine componentiv, while others contain territorial restrictionsv. [...] These agreements also depend on the “willingness” of the technology holder to license at all and as such are failing to mobilise global manufacturing capacity and diversifying supply options, on transparent terms that prioritize boosting global supply of the vaccine components and the final product. [...] We believe that the way forward should be to remove barriers towards the development, production and approval of vaccines, therapeutics and other medical technologies necessary for the prevention, containment and treatment of the COVID-19 pandemic, so that more manufacturers, especially from developing countries, may independently contribute to the global supply. [...] Coalition for Research and Action for Social Justice and Human Dignity, Finland 103. [...] Zimbabwe National Network of PLHIV (ZNNP+), Zimbabwe i Enhancing the role of the World Trade Organization in the global effort toward the production and distribution of Covid-19 vaccines and other medical products.
Pages
7
Published in
United States of America

Tables